J. Audia
Molecular Biology · 2000–2016
A researcher in the Science corpus: 3 papers; trusts 5 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 50 citations into it; #15,769 of 17,773 by trust here, #12,008 by citations
Whom J. Audia trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Andrew J. Bannister
- S. Baylin
- Tony Kouzarides
- E. Seto
- Peter A. Jones
- Steve Horvath
- N. Iyer
- R. Houtkooper
- Joshua C. Black
Who trusts J. Audia overall
Papers from J. Audia's perspective
Ordered by how strongly the researchers J. Audia trusts endorse each paper. Same corpus, a different order for every researcher.
- Global histone modification patterns predict risk of prostate cancer recurrence (Nature)
- EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer (EMBO Journal)
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer (Nature Genetics)
- Multivalent engagement of chromatin modifications by linked binding modules (Nature reviews. Molecular cell biology)
- BET bromodomain inhibition as a therapeutic strategy to target c-Myc (Cell)
- Epigenetic antagonism between Polycomb and SWI/SNF complexes during oncogenic transformation (Cancer Cell)
- Frequent mutation of histone modifying genes in non-Hodgkin lymphoma (Nature)
- Selective inhibition of BET bromodomains (Nature)
- Targeting MYC dependence in cancer by inhibiting BET bromodomains (Proceedings of the National Academy of Sciences of the United States of America)
- Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. (Genes & Development)
Their papers
- Histone Modifications and Cancer. (2016) — 859 citations
- The promise and peril of chemical probes (2015) — 739 citations
- Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain (2000) — 884 citations